🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟Congratulations to William L Hwang Mass General Cancer Center--2025 NETRF Research Award recipient! His focus: Exploring how nerves around pancreatic neuroendocrine tumors impact cancer growth & outcomes.More:netrf.org/research/role-… #neuroendocrinecancer #PNETs

Congrats to Dr Philippe Joubert University Laval-new NET Research Foundation Investigator Awardee!Dr. Joubert studies diffuse idiopathic pulmonary neuroendocrine cell hyperplasia to improve diagnoses & reveal how DIPNECH progresses to #neuroendocrinecancer 🔗More: tinyurl.com/y9xuh5cw

📣Tell NET Research Foundation what you need to KNOW YOUR NETs! Your feedback is important as we plan our #2025KNOWYOURNETs conference. Please take 5 minutes to give us your two cents. 💻Take our survey:s.surveylegend.com/-OELAfUlQp8zCc… #neuroendocrinecancer #NETs #NECs

📢Calling to #PrimaryCarePhysicians! We have a free online NEN program, designed with your practice in mind from top PCPs and NEN experts. Free CME credit. Available in 6 languages. 📌Enroll now to #ThinkNENs: incalliance.org/think-nens/ #LetsTalkAboutNETs #InternalMedicine

Mentored Research Awardee Qianjin Guo, Stanford Medicine is studying new strategies for SDHB-deficient metastatic #pheochromocytoma & #paraganglioma.Tumors with SDHB have 30% risk of metastasis.He seeks tumor vulnerabilities,for potential targeted treatments.tinyurl.com/4ejek57k

👉New NETWise Episode! Happiness is something that can be difficult to find,especially now. Having #neuroendocrinecancer makes it harder. In the latest #NETWisePodcast -what happiness means&how cancer can affect it. tinyurl.com/ym2693t2

📣Calling neuroendocrine cancer researchers! @CureNets 2025 Request for Applications is OPEN. LOIs due March 17. #neuroendocrinecancer #fundingopportunity #cancerresearch

Congrats to NETRF Grant Recipient Dr. Ramesh Shivdasani Dana-Farber News.His research studies how normal intestinal #neuroendocrine cells turn cancerous. This work provides insights into #NETs identifying pathways that could lead to new treatments. tinyurl.com/mst3njcv

It's #NETRFNews time! Our February issue is here. Read about grant opportunities, promising research, AI and #neuroendocrinecancer, #Thrivership, and how you can support NET Research Foundation. More:tinyurl.com/yx6a763s #cancerreserach #NETs #NECs

Apply by March 17, 2025! NET Research Foundation is looking for #neuroendocrinecancer researchers with innovative ideas. We are funding! #cancerresearch #NETs #NECs

⏰Less than a week left to submit a Letter of Intent for a NET Research Foundation research grant.We want to see your proposal for innovative approaches to treat #Neuroendocrinecancer. Deadline is March 17, 5PM Eastern. More:netrf.org/for-researcher… #cancerresearch

⏰Tomorrow is the deadline for LOIs for NET Research Foundation 2025 research grants. We fund transformative basic, translational, and clinical projects to develop or improve treatments. tinyurl.com/4w53nf2n Submit by 3/17, 5P Eastern: proposalcentral.com #NETs

📣NETRF Research News Alert! Read about the latest in #neuroendocrinecancer research in our new issue. tinyurl.com/4bykeymh #NETs #NECs #CancerResearch Neuroendocrine Cancer Foundation NANETS Pheo Para Alliance

Attending Penn Medicine 14th Annual Focus on Neuroendocrine Tumors today? If so, stop by the NETRF table to explore our resources and chat with our Director of Patient Education, Jessica Thomas, LCSW! #neuroendocrinecancer #NETs #NECs

This is a major development in treatment for #neuroendocrinecancer ! Thanks to the patients, physicians, and Exelixis who made this possible. Special kudos to Dr. Jenn Chan of Dana-Farber who was PI for the clinical trial. #NETs

Cancer doesn’t just take a toll on the body—it also hits hard financially.In the latest episode of NETRF’s #NETWise we explore the economic impact of a neuroendocrine cancer diagnosis. Listen for advice on how to manage treatment costs.netrf.org/podcast/managi…

📢 PATIENT BREAKTHROUGH: Yesterday, the FDA approved belzutifan, the first approved treatment for patients with advanced and inoperable pheochromocytoma and paraganglioma. Learn more: fda.gov/drugs/resource… #pheo #para #PPGL #Neuroendocrinecancer

Congratulations Amit Tirosh NET Research Foundation celebrates your recognition and is proud to have supported your work! #neuroendocrinecancer #cancerresearch

We are encouraged by the positive news from this landmark trial for #neuroendocrinetumors. Thank you Chimeric Therapeutics ASX: CHM for your commitment to this #clinicaltrial and our #NETs community. NET Research Foundation is proud of our support of the preclinical work that made this possible. #cancerresearch